At the 2025 American Society of Hematology (ASH) Annual Meeting, Brady Stein, MD, chaired a session introducing the forthcoming ASH Clinical Practice Guidelines on Myelofibrosis—the first ASH-supported...
How can primary care clinicians diagnose and manage IBS-C and chronic idiopathic constipation? Joel J. Heidelbaugh, MD, outlines evidence-based treatment options, alarm features, and when to refer to...
How can primary care clinicians diagnose and manage IBS-C and chronic idiopathic constipation? Joel J. Heidelbaugh, MD, outlines evidence-based treatment options, alarm features, and when to refer to...
How can primary care clinicians diagnose and manage IBS-C and chronic idiopathic constipation? Joel J. Heidelbaugh, MD, outlines evidence-based treatment options, alarm features, and when to refer to...
How can primary care clinicians diagnose and manage IBS-C and chronic idiopathic constipation? Joel J. Heidelbaugh, MD, outlines evidence-based treatment options, alarm features, and when to refer to...
How can primary care clinicians diagnose and manage IBS-C and chronic idiopathic constipation? Joel J. Heidelbaugh, MD, outlines evidence-based treatment options, alarm features, and when to refer to...
In this interview, Robert Hegele, MD, discusses the diagnosis and management of sHTG-related chylomicronemia syndrome, including pancreatitis risk reduction, dietary intervention, genetic testing, and...
In this interview, Robert Hegele, MD, discusses the diagnosis and management of sHTG-related chylomicronemia syndrome, including pancreatitis risk reduction, dietary intervention, genetic testing, and...
In this interview, Robert Hegele, MD, discusses the diagnosis and management of sHTG-related chylomicronemia syndrome, including pancreatitis risk reduction, dietary intervention, genetic testing, and...
In this interview, Robert Hegele, MD, discusses the diagnosis and management of sHTG-related chylomicronemia syndrome, including pancreatitis risk reduction, dietary intervention, genetic testing, and...
